Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Family Practice
|
October 6, 2021
Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries
Dan Ouchi, Ana García-Sangenís, Ana Moragas, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 6, 2022
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
Theo J Verheij, Daniela Cianci, Alike W van der Velden, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countries
Xiao Li, Joke Bilcke, Alike W van der Velden, et al.
BMJ Open
|
July 14, 2018
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC<sup>4</sup> E): the ALIC<sup>4</sup> E protocol
Emily Bongard, Alike W van der Velden, Johanna Cook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2024
Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis
Alice X T Xu, Kevin Brown, Kevin L Schwartz, et al.
Lancet (London, England)
|
December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
Christopher C Butler, Alike W van der Velden, Emily Bongard, et al.
BMJ (Clinical Research Ed.)
|
September 5, 2020
A living WHO guideline on drugs for covid-19
Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Family Practice
|
October 6, 2021
Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries
Dan Ouchi, Ana García-Sangenís, Ana Moragas, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 6, 2022
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
Theo J Verheij, Daniela Cianci, Alike W van der Velden, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countries
Xiao Li, Joke Bilcke, Alike W van der Velden, et al.
BMJ Open
|
July 14, 2018
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC<sup>4</sup> E): the ALIC<sup>4</sup> E protocol
Emily Bongard, Alike W van der Velden, Johanna Cook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2024
Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis
Alice X T Xu, Kevin Brown, Kevin L Schwartz, et al.
Lancet (London, England)
|
December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
Christopher C Butler, Alike W van der Velden, Emily Bongard, et al.
BMJ (Clinical Research Ed.)
|
September 5, 2020
A living WHO guideline on drugs for covid-19
Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
Page
of 11